A key finding is a lack of a close correlation between varying degrees of EGFR expression in tumour cells and their sensitivity to EGFR TKI inhibitors such that low-level EGFR tumours can be more sensitive than tumours with high receptor expression (Parra et al, 2002; Ciardiello et al, 2003). Here, EGFR is linked to neoplasm.